POCT news

Point-of-Care Testing (POCT) delivers rapid clinical assays performed in close proximity to patients. Based on dry fluorescent immunoassay technology, it supports specimens including whole blood, serum, plasma and urine for bedside settings such as emergency departments, chest pain centers, ICUs, general practices and community clinics. Its core advantages lie in speed and proximity, enabling clinicians or patients to obtain critical diagnostic information promptly.

A Point-of-Care (POCT) analyzer, commonly known as a bedside testing device, is a portable or compact bench-top in vitro diagnostic instrument. It performs tests on-site at the point where patient samples are collected, independent of the central clinical laboratory. With matched test cartridges/strips, it delivers test results within minutes.

POCT (Point-of-Care Testing), also known as bedside testing, refers to rapid testing and result acquisition performed on-site where patient samples are collected, using portable analytical instruments and matched reagents. Centered on immediacy and convenience, POCT eliminates reliance on specialized laboratories and streamlines workflows to cut turnaround time. Labsim’s POCT Analyzer paired with Fluoroimmunoassay (FIA) Reagents delivers rapid test results.